Iron and Vitamin D/Calcium Deficiency after Gastric Bypass: Mechanisms Involved and Strategies to Improve Oral Supplement Disposition
-
Published:2019-05-22
Issue:3
Volume:20
Page:244-252
-
ISSN:1389-2002
-
Container-title:Current Drug Metabolism
-
language:en
-
Short-container-title:CDM
Author:
Mangan Aisling1, Le Roux Carel W.1, Miller Nana Gletsu2, Docherty Neil G.1
Affiliation:
1. Diabetes Complications Research Center, Conway Institute, University College Dublin, Dublin, Ireland 2. Nutrition Department, Purdue University, Indiana, IN, United States
Abstract
Background:Nutritional deficiencies are common following Roux-en-Y Gastric Bypass (RYGB). Aetiology is diverse; including non-compliance, altered diet, unresolved preoperative deficiency and differential degrees of post-operative malabsorption occurring as function of length of bypassed intestine. Iron and calcium/vitamin D deficiency occur in up to 50% of patients following RYGB. Currently, treatment strategies recommend the prescription of oral supplements for those who become deficient. Meanwhile, debate exists regarding the absorption capacity of these post-operatively and their efficacy in treating deficiency.Objective:To examine the disposition of oral iron and calcium/vitamin D supplementation following RYGB. Methods: A literature review was carried out using PubMed and Embase. Data from the key interventional studies investigating iron and calcium/vitamin D oral supplement absorption and efficacy following RYGB was summarized.Results:Absorption of both iron and vitamin D/calcium is adversely affected following RYGB. Distribution and metabolism may be altered by the predominance of paracellular absorption pathways which promote unregulated influx into the circulatory system. Overall, studies indicate that current supplementation strategies are efficacious to a degree in treating deficiency following RYGB, generally restoration of optimal status is not achieved.Conclusion:Oral supplement disposition is altered following RYGB. As a result, patients are required to take regimens of oral supplementation indefinitely. The dosage which confers optimum health benefit while avoiding potential toxicity and tolerability issues remains unknown. Novel preparations with improved disposition could help limit the extent of post-RYGB nutritional deficiencies.
Publisher
Bentham Science Publishers Ltd.
Subject
Clinical Biochemistry,Pharmacology
Reference104 articles.
1. Salgado W, Modotti C, Nonino CB, Ceneviva R. SOARD, Anemia and iron deficiency before and after bariatric surgery.,, 2014, 10,, 49-54, 2. World Helath Organisation - Obesity and Overweight, . http://www.who.int/mediacentre/factsheets/fs311/en/, , (Accessed September 4, 2017)., 3. Flegal KM, Kruszon-Moran D, Carroll MD, Fryar CD, Ogden CL. JAMA, Trends in obesity among adults in the United States, 2005 to 2014.,, 2016, 315,, 2284-2291, 4. Laura M, Segal JR, Alejandra M, The state of obesity: Better policies for a healthier America. Health, Trust for America’s Health, Ed.; Washington,, ,, , , , 2016,- 5. Stein J, Stier C, Raab H, Weiner R. Aliment Pharmacol Ther, Review article: The nutritional and pharmacological consequences of obesity surgery.,, 2014, 40,, 582-609,
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|